GlassScriptPhysician profile
Adam L Stelzer
NPI 1265623086
$12,180.86
in general payments reported to CMS, 2019-2025
21 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,751 · 2020: $2,472 · 2021: $3,217 · 2022: $2,443 · 2023: $984 · 2024: $183 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,296.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $4,409.83 | 2019-2023 | Cequa |
| Coopervision INC. | $1,470.13 | 2019-2023 | Myday Contact Lens, Misight Contact Lens |
| Allergan, INC. | $1,151.70 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $1,062.02 | 2019-2023 | Acuvue |
| Bausch & Lomb Americas INC. | $771.69 | 2022-2023 | Infuse |
| Sight Sciences, INC. | $572.11 | 2019-2022 | |
| Abbvie INC. | $502.22 | 2022-2023 | Alphagan P, Vuity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $442.76 | 2019-2021 | |
| Alcon Vision LLC | $419.01 | 2022-2025 | Hydrus Microstent, Precision7 |
| Maculogix, INC. | $256.38 | 2020 | |
| Novartis Pharmaceuticals Corporation | $199.97 | 2019-2023 | |
| Visionix USA, INC | $186.02 | 2022 | |
| Optos, INC. | $153.51 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $124.99 | 2021 | |
| Genzyme Corporation | $121.99 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $82.77 | 2022-2024 | Tyrvaya |
| Shire North American Group INC | $78.29 | 2019 | |
| Lumibird Medical INC. | $53.88 | 2019 | |
| Abb Con-Cise Optical Group LLC | $50.00 | 2019 | |
| Biotissue Holdings INC. | $43.81 | 2021 | |
| Glaukos Corporation | $27.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Stelzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.